Chronic wounds that fail to heal despite standard treatments present a major challenge for both patients and healthcare providers. However, a groundbreaking study led by Dr. Yadwinder Dhillon, Medical Director at Arizona Wound & Hyperbaric Medicine, provides new hope for those suffering from refractory wounds.
Published in Advances in Wound Care, this real-world clinical study evaluates the effectiveness of a Multimodal Wound Matrix (MWM) in treating chronic, nonhealing wounds, including diabetic foot ulcers, venous leg ulcers, pressure injuries, and surgical wounds.
Key Findings
As the study’s lead investigator, Dr. Dhillon played a pivotal role in assessing the impact of the Multimodal Wound Matrix (MWM)—an advanced bioactive wound care technology designed to address key barriers to healing, such as inflammation, biofilm, and poor circulation—on patients with complex comorbidities, a group often excluded from traditional clinical trials. The key findings included:
-
MWM moved 37/53 nonhealing wounds that had failed prior therapy toward healing.
- MWM had responses in all types and age duration of nonhealing wounds.
- By week 12, MWM closed 18/53 wounds (100% reepithelialization with no drainage).
- By week 12, MWM had reduced the wounds in size by an average 66%.
Why This Research Matters
Dr. Dhillon and the research team designed this study to better reflect real-world wound care challenges, rather than the controlled conditions of traditional clinical trials. The findings highlight MWM as a powerful tool for treating wounds that have failed previous therapies, giving new hope to patients and expanding treatment options for clinicians.
Learn More
Dr. Dhillon remains at the forefront of wound care innovation, helping patients achieve better outcomes through cutting-edge treatments and research-driven care.
➡ Read the full study here: https://www.liebertpub.com/doi/10.1089/wound.2024.0189
For more information about advanced wound care at Arizona Wound & Hyperbaric Medicine, contact us today.
